Delivery Order SPE2DR25D1110-SPE2DR26F13EM
Award Date 12/3/25
Potential Completion Date 12/4/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,198.50 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-set-aside award made through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Corporate Office location. The delivery order...
- The Defense Logistics Agency awarded a $18,335.22 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of XELJANZ XR 11 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a performance location in Conshohocken, Pennsylvania. The delivery order is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,656.94 on December 18, 2025, for the supply of XELJANZ XR 11 mg tablets (30-count units) under a firm fixed-price contract with the Defense Logistics Agency. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by December 19, 2025, with performance taking place at the vendor's corporate office location in Conshohocken. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,086.72 to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, demonstrating competitive award through open procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of December 19, 2025. This delivery...
- The Defense Logistics Agency awarded a $27,498.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XELJANZ 10 mg tablets (60-count units) with an ultimate completion date of December 5, 2025. This non-set-aside contract was awarded competitively on December 4, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 master contract...
- The Defense Logistics Agency awarded a $3,198.50 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for XELJANZ XR 11 MG tablets in 30-count units. This is a firm fixed price, non-set-aside contract with performance completion scheduled for July 29, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location in the same city. The contract represents a child delivery order under...
- The Defense Logistics Agency awarded a $17,639.67 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $17,873.07 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 8, 2025, for XELJANZ XR 11 mg tablets (30-count packages). The award, which carries an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,198.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (quantity: 30 units), with an ultimate completion date of June 20, 2025. This non-set-aside competitive award was issued on June 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.60 to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, headquartered in...